A sitting governor said on national TV he lost 80 pounds using a weekly GLP-1 and said it changed his life.
Story Snapshot
- Illinois Governor J.B. Pritzker said he has used a GLP-1 for two years.
- He reported an 80-pound weight loss and called the treatment life changing.
- He linked the medication to a type 2 diabetes diagnosis and medical advice.
- His office said he no longer uses insulin and has non-diabetic levels.
Pritzker’s On‑Air Disclosure and Core Health Claims
Governor J.B. Pritzker disclosed on CBS Mornings that he has been using a glucagon-like peptide 1 medication and has lost 80 pounds. He said he gives himself a weekly injection and described the change as life changing.
He tied the decision to a type 2 diabetes diagnosis from two years ago. He said doctors warned he would likely need insulin, which spurred action. Coverage of the broadcast repeated his 80-pound figure and quoted his description of feeling better.
Reports on the interview said he denied that the weight loss was about a White House bid, and said it was about health. The governor’s office added that, with the medication plus diet and exercise, he no longer takes insulin and now has lab numbers in the non-diabetic or prediabetic range.
The name of the specific drug and the exact start date were not given in the coverage, which framed his remarks as a personal health update amid national political chatter.
The Diabetes Link and What GLP-1 Drugs Do
Pritzker connected his choice to his diabetes diagnosis, which matches how these drugs are often prescribed. Glucagon-like peptide 1 medications help the body release insulin after meals.
They slow stomach emptying and reduce appetite. Many patients lose weight and see lower average blood sugar. These medicines can lower the need for insulin in some people with type 2 diabetes. Pritzker’s report of weight loss and stopping insulin fits that pattern, though individual results vary.
He said he injects weekly, which matches the dosing schedule for several brands in this class. He also credited diet and exercise.
That point tracks standard care. Doctors usually pair these medications with food changes, daily movement, and steady sleep.
That mix often brings the best results. Pritzker said he feels a whole lot better, which is common when weight, blood sugar, and energy improve together.
Public Health, Private Choice, and the Politics Around It
The announcement landed in a culture fight about these drugs. Many Americans see strong benefits but worry about cost and fairness. Studies and reviews describe uneven access tied to high prices and mixed insurance coverage.
Lower income and minority groups often face more barriers. As a result, who gets the drug can shape public views about it. Those debates now follow every high-profile user, no matter the medical need.
Illinois Gov. JB Pritzker discloses diabetes diagnosis, 80-pound weight loss on GLP-1 drug https://t.co/GkdAL0okbu
— Chicago Breaking News (@ChicagoBreaking) September 22, 2026
Coverage also noted policy context in Illinois. Reports highlighted that the state covers these drugs for many workers and that the governor linked coverage to savings from better health.
Supporters of broad coverage point to fewer hospital visits and reduced complications. Skeptics focus on near-term cost and possible overuse.
What His Statement Does—and Does Not—Settle
The CBS interview set several facts in public view. The governor says he used a GLP-1 for about two years, injects weekly, lost 80 pounds, and feels better. Reports state he tied the treatment to a diabetes diagnosis and doctor guidance.
His office says he stopped insulin and has non-diabetic or prediabetic levels now. Those points define the health arc he wanted voters to understand. They also explain why the story blends medicine with politics in a campaign season.
Sources:
x.com, cbsnews.com, axios.com, chicagotribune.com, newser.com, pmc.ncbi.nlm.nih.gov
